Sponsor or institution
Clinical trials and research at Chengdu New Radiomedicine Technology Co. LTD.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Chengdu New Radiomedicine Technology Co. LTD. that are recruiting, in China. By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
68Ga/177Lu-NRT6020 imaging and targeted therapy for FAP-positive advanced solid tumors
This trial tests a PET imaging agent (68Ga-NRT6020) to find FAP-positive tumors and a linked radioactive treatment (177Lu-NRT6020) to see if it is safe and shows early benefit in adults with advanced solid tumors.
-
Evaluating NRT6008 for patients with advanced pancreatic cancer
This study is testing a new injection called NRT6008 to see if it is safe and effective for people with advanced pancreatic cancer that can't be removed by surgery.
Quick answers
How many clinical trials run by Chengdu New Radiomedicine Technology Co. LTD. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.